RYTM · Rhythm Pharmaceuticals, Inc. · Executive Compensation

$115.02 +5.16 (+4.70%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$7.97B

69.33M

Volume · Nov 13 1.16M Avg daily vol (3M) 997.95K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David P. Meeker, M.D.	Chief Executive Officer	$807,692	—	$8,274,785	$7,688,560	$759,488	$14,000	$17,544,525
David Meeker	Chief Executive Officer	$807,692	—	$8,274,785	$7,688,560	$759,488	$14,000	$17,544,525
Hunter Smith	Chief Financial Officer	$540,477	—	$2,933,277	$2,402,675	$338,000	$14,000	$6,228,429
Yann Mazabraud	Executive Vice President, Head of International	$557,231	—	$2,839,739	$2,306,568	$344,659	$70,258	$6,118,455
Jennifer Lee	Executive Vice President, Head of North America	$531,635	—	$2,649,827	$2,114,354	$293,000	$14,000	$5,602,816
Alastair Garfield	Chief Scientific Officer	$505,385	—	$2,082,927	$1,537,712	$287,000	$14,000	$4,427,024

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David P. Meeker, M.D.	Chief Executive Officer	$740,472	—	$4,382,955	$8,784,115	$744,135	$12,065	$14,663,742
David Meeker	Chief Executive Officer	$740,472	—	$4,382,955	$8,784,115	$744,135	$12,065	$14,663,742
Yann Mazabraud	Executive Vice President, Head of International	$467,224	—	$1,999,709	$2,272,339	$297,075	$58,923	$5,095,270
Hunter Smith	Chief Financial Officer	$499,385	—	$1,458,419	$2,726,806	$352,000	$13,800	$5,050,410
Jennifer Lee	Executive Vice President, Head of North America	$488,266	—	$1,241,807	$2,272,339	$302,000	$13,800	$4,318,212

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David P. Meeker, M.D.	Chief Executive Officer	$704,715	—	$1,545,275	$4,334,521	$634,053	$11,893	$7,230,457
David Meeker	Chief Executive Officer	$704,715	—	$1,545,275	$4,334,521	$634,053	$11,893	$7,230,457
Hunter Smith	Chief Financial Officer	$476,154	—	$538,795	$1,011,892	$261,000	$20,166	$2,308,007
Jennifer Lee	Executive Vice President, Head of North America	$464,731	—	$493,668	$885,405	$246,000	$16,406	$2,106,210
Yann Mazabraud	Executive Vice President, Head of International	$448,848	—	$805,100	—	$238,688	$249,373	$1,742,009
Joseph Shulman	Chief Technical Officer	$430,192	—	$430,763	$632,432	$226,000	$21,081	$1,740,468

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Meeker	Chief Executive Officer	$652,050	—	—	$2,157,300	$505,420	$10,988	$3,325,758
David P. Meeker, M.D.	Chief Executive Officer	$652,050	—	—	$2,157,300	$505,420	$10,988	$3,325,758
Hunter Smith	Chief Financial Officer	$460,000	—	$110,500	$412,425	$217,000	$15,200	$1,215,125
Yann Mazabraud	Executive Vice President, Head of International	$380,643	—	$93,500	$348,975	$202,697	$164,090	$1,189,905
Jennifer Chien	Executive Vice President, Head of North America	$430,000	—	$93,500	$348,975	$202,000	$12,200	$1,086,675
Jennifer Lee	Executive Vice President, Head of North America	$430,000	—	$93,500	$348,975	$202,000	$12,200	$1,086,675
Joseph Shulman	Chief Technical Officer	$410,000	—	$72,250	$269,663	$186,000	$12,200	$950,113

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Meeker	Chief Executive Officer	$630,000	—	$1,164,842	$4,204,200	$450,954	$8,364	$6,458,360
David P. Meeker, M.D.	Chief Executive Officer	$630,000	—	$1,164,842	$4,204,200	$450,954	$8,364	$6,458,360
Hunter Smith	Chief Financial Officer	$435,957	—	$576,264	$1,074,938	$210,654	$11,600	$2,309,413
Yann Mazabraud	Executive Vice President, Head of International	$384,250	—	$552,376	$931,613	$190,864	$118,502	$2,177,605
Jennifer Lee	Executive Vice President, Head of North America	$395,000	—	$552,376	$931,613	$190,864	$11,600	$2,081,453
Jennifer Chien	Executive Vice President, Head of North America	$395,000	—	$552,376	$931,613	$190,864	$11,600	$2,081,452
Murray Stewart	Former Chief Medical Officer	$365,837	—	$320,487	$1,074,938	$187,890	$41,600	$1,990,752
Joseph Shulman	Chief Technical Officer	$386,250	—	$516,545	$716,625	$157,223	$11,600	$1,788,243

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David P. Meeker, M.D.	Chief Executive Officer	$262,308	—	$918,500	$12,844,897	$207,958	$43,704	$14,277,367
David Meeker	Chief Executive Officer	$262,308	—	$918,500	$12,844,897	$207,958	$43,704	$14,277,367
Keith M. Gottesdiener	Former President and Chief Executive Officer	$142,906	—	—	$2,810,726	—	$495,537	$3,449,169
Hunter Smith	Chief Financial Officer	$416,118	$60,000	$132,000	$1,837,630	$209,595	$7,125	$2,662,468
Murray Stewart	Former Chief Medical Officer	$451,169	$60,000	$113,000	$1,555,420	$226,600	$7,125	$2,300,314
Nithya Desikan	Former Chief Commercial Officer	$305,510	—	$105,000	$1,533,841	—	$104,620	$1,943,971
Jennifer Chien	Executive Vice President, Head of North America	$45,577	$100,000	$100,000	$1,517,540	$49,375	$7,125	$1,819,617

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Keith M. Gottesdiener	Former President and Chief Executive Officer	$525,934	—	—	$4,133,768	$277,340	—	$4,937,042
Hunter Smith	Chief Financial Officer	$393,992	—	—	$1,286,061	$153,224	$86,576	$1,922,853
Nithya Desikan	Former Chief Commercial Officer	$379,063	—	—	$1,286,061	$145,117	—	$1,810,241

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Keith M. Gottesdiener	M.D. , Former President and Chief Executive Officer	$505,519	—	—	$2,756,250	$278,035	—	$3,539,804
Hunter Smith	Chief Financial Officer, Treasurer, Secretary and Interim President and Chief Executive Officer	$387,600	—	—	$960,750	$152,211	$86,576	$1,587,137

Executive changes

Person	Role	Change	Effective	Filed
Edward T. Mathers	Board	Resigned	2026-04-01	2026-04-03
Kimberly J. Popovits	non-employee director	Appointed	2026-04-01	2026-04-03
Camille L. Bedrosian, M.D.	Board	Resigned	2025-12-16	2025-12-19
William T. Roberts	Chief Accounting Officer	Terminated	2023-08-11	2023-08-08

Leadership

David P. Meeker, M.D. CEO, Chairman
Hunter Smith CEO, CFO
David Meeker Chairman
Christophe R. Jean Board Member
David W. J. McGirr Board Member
Jennifer Good Board Member
Kimberly J. Popovits Board Member
Lynn A. Tetrault Board Member
Stuart A. Arbuckle Board Member

Key facts CIK 1649904 CUSIP 76243J105 13F (30d) 263 filings 226 filers Visit website Investor relations